Results for tag: "Fc Gamma Receptor Antagonist"

The Fc Gamma Receptor Antagonist market is a subset of the Immune Disorders Drugs market. Fc Gamma Receptor Antagonists are drugs that target the Fc gamma receptor, a protein found on the surface of immune cells. These drugs are used to treat a variety of immune-related disorders, including autoimmune diseases, inflammatory diseases, and allergies. Fc Gamma Receptor Antagonists work by blocking the receptor, preventing it from binding to antibodies and triggering an immune response. This can help reduce inflammation and other symptoms associated with immune disorders. The Fc Gamma Receptor Antagonist market is a rapidly growing segment of the Immune Disorders Drugs market, with a number of companies developing new drugs and treatments. Companies in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more